Not all patients received head CT scans, so the results are not generalizable, but among those who did undergo head CT, 11% had intracranial hemorrhage.
Intracranial hemorrhage (ICH) is a known cause of out-of-hospital cardiac arrest (OHCA), especially in East Asia (NEJM JW Emerg Med Nov 2009 and Resuscitation 2009; 80:977). Investigators reviewed charts from three emergency departments in Korea over a 6-year period to determine the proportion of patients with return of spontaneous circulation after OHCA who had ICH.
Of 2716 patients with OHCA, 804 had return of spontaneous circulation and underwent head computed tomography (CT). Of these 804 patients, 11% were found to have ICH. Of the patients with ICH, 11% survived to discharge and none had good neurological outcome at 1 month, whereas among patients without ICH, 40% survived and 16% had good neurological outcome.
Reviewing Author
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals
DisclosuresConsultant/Advisory BoardPortola Pharmaceuticals, Inc.
Speaker’s BureauPeerView Institute for Medical Education
Grant/Research SupportAgency for Healthcare Research and Quality; CDC; NIH–National Center for Advancing Translational Sciences; NIH–National Institute of Allergy and Infectious Diseases (NIAID); NIH–NIAID–Antibacterial Resistance Leadership Group; Merck; Pfizer; Boehringer-Ingelheim; Shire; Portola Pharmaceuticals, Inc.; Novartis; bioMérieux; Siemens; Rapid Pathogen Screening; Magnolia; Stago; Innovative Biosensors; Molecular Detection, Inc.; Dyax Corp.; Trius Pharmaceuticals